Patent · US Active

Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide

US9567358B2 · kind B2 · utility

0Cited by
5References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2015
Grant dateFeb 14, 2017
Priority date
Expiry dateMar 18, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Quinazoline derivatives of formula (I):wherein A is 5-membered heteroaryl containing a nitrogen atom and one or two further nitrogen atoms; compositions containing them, processes for their preparation and their use in therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.